abstract |
(57) [Summary] [Structure] A therapeutic agent for a tumor having a high level of pp60 c-src kinase activity, which comprises a protein tyrosine phosphatase α inhibitor. [Effect] The above inhibitor is particularly effective for treating human colon cancer. |